Routine restaging after primary non-surgical treatment of laryngeal squamous cell carcinoma-a review.
Caroline Theresa SeebauerBerit HackenbergJirka GrosseJanine RennertErnst-Michael JungInes UgeleIoannis MichaelidesHisham MehannaMatthias G HautmannChristopher BohrJulian KünzelPublished in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2020)
Studies evaluating restaging methods after organ-preserving non-surgical treatment of laryngeal carcinoma are limited. As radiotherapy (RT), chemoradiotherapy (CRT), systemic therapy followed by RT and radioimmunotherapy are established alternatives to surgical treatment, particularly in advanced laryngeal cancers, further studies are needed to assess and compare different imaging modalities (e.g. PET/CT, MRI, CT, ultrasound) and clinical diagnostic tools (e.g., video laryngoscopy, direct laryngoscopy) to offer patients safe and efficient restaging strategies. PET or PET/CT 3 months after initial treatment followed by direct laryngoscopy with biopsy of the identified lesions has the potential to reduce the number of unnecessary laryngoscopies.
Keyphrases
- pet ct
- positron emission tomography
- squamous cell carcinoma
- locally advanced
- magnetic resonance imaging
- end stage renal disease
- contrast enhanced
- computed tomography
- ejection fraction
- peritoneal dialysis
- early stage
- ultrasound guided
- high resolution
- rectal cancer
- prognostic factors
- radiation therapy
- stem cells
- heart failure
- bone marrow
- combination therapy
- mass spectrometry
- climate change
- fluorescence imaging
- human health
- image quality
- photodynamic therapy
- replacement therapy